Drug Type Small molecule drug |
Synonyms + [3] |
Target |
Mechanism MAPKAPK2 inhibitors(MAP kinase-activated protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H16FN3OS |
InChIKeyCDMGBJANTYXAIV-UHFFFAOYSA-N |
CAS Registry152121-47-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Adezmapimod | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | 07 Mar 2000 |